Home > Pharmacy guidance on smoking and mental disorder.

Campion, Jonathan and Hewitt, Jed and Shiers, David and Taylor, David (2017) Pharmacy guidance on smoking and mental disorder. London: Royal College of Psychiatrists, National Pharmacy Association and Royal Pharmaceutical Society.

[img]
Preview
PDF (Pharmacy guidance on smoking)
533kB

• Smoking is the single largest cause of preventable death in the UK and a major determinant of health inequality for those with a mental disorder.
• With appropriate support, those with a mental disorder are able to stop smoking.
• Doses of some psychiatric medication require significant reduction following smoking cessation.
• A range of pharmacological interventions (such as combination nicotine replacement therapy or varenicline) and non-pharmacological interventions are effective in supporting smoking cessation for people with a mental disorder.
• Pharmacists have a key role in improving access to smoking cessation and reduction interventions for smokers with a mental disorder as well as facilitating appropriate changes of medication doses.

Pharmacists are ideally placed:
• to encourage patients to stop smoking,
• to explain the benefits of smoking cessation
• to support smoking reduction as a first step to cessation promoting a healthier lifestyle
• to counsel patients on the lifestyle change
• to facilitate change to patients’ medication doses where appropriate


Item Type
Report
Publication Type
International, Guideline, Report
Drug Type
Tobacco / Nicotine
Intervention Type
General / Comprehensive, Prevention, Harm reduction
Date
April 2017
Pages
4 p.
Publisher
Royal College of Psychiatrists, National Pharmacy Association and Royal Pharmaceutical Society
Place of Publication
London
EndNote
Related (external) link

Repository Staff Only: item control page